Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Identifying MRI-Defined Optic Pathway Glioma in NF1 Using Macular OCT and Machine Learning.

Created on 19 Nov 2026

Authors

Ayelet Goldstein, Carlos Fresno Cañada, Joan Gispets

Published in

Translational vision science & technology. Volume 15. Issue 11. Pages 18. Nov 02, 2026.

Abstract

To evaluate whether macular optical coherence tomography (OCT) distinguishes eyes with versus without recorded magnetic resonance imaging (MRI)-defined eye-level optic pathway glioma (OPG) status in neurofibromatosis type 1, and whether longitudinal OCT, visual/clinical variables, optic-nerve, or single-feature OCT add value.
One study eye was selected per participant independently of OPG status. The retrospective cohort included 182 participants (58 OPG-positive and 124 OPG-negative eyes). Six primary feature sets compared baseline and longitudinal macular OCT, with and without clinical/visual variables, plus clinical/visual variables alone and visual acuity (VA) alone. Paired macular versus optic-nerve analyses used 141 participants with at least two paired examination dates.
Baseline macular OCT achieved pooled out-of-fold area under the precision-recall curve (PR-AUC) 0.819 and area under the receiver operating characteristic curve (ROC-AUC) 0.870, versus 0.551 and 0.667 for VA alone. Longitudinal summaries and added clinical/visual variables provided no clear gain. Baseline macular and optic-nerve OCT showed similar discrimination in the paired cohort (PR-AUC 0.787 vs. 0.802). Macular ganglion cell complex (GCL++) alone achieved PR-AUC 0.819 and ROC-AUC 0.844. Of 58 OPG-positive eyes, 31 (53.4%) had preserved baseline VA; among participants with preserved VA, baseline macular OCT retained discrimination (PR-AUC 0.701; ROC-AUC 0.831).
Macular OCT provided structural information beyond VA and showed similar discrimination to optic-nerve OCT. Longitudinal summaries offered no clear gain over baseline OCT, while GCL++ alone showed strong discrimination.
Simple macular OCT measures may complement clinical assessment and MRI surveillance but require external validation before clinical use.

PMID:
43055549
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement